| |
Sandor was started in 1995 with the aim of providing high technology medical Therapeutics, devices and equipments to the Indian health care industry. The company launched path breaking concepts in the country since its inception. The point of care diagnostic concept was the first to be launched followed by automatic reprocessing of dialysers. Over time the company has earned itself distinction as a reliable provider of high-end technology and dependable service. To achieve the above goals Sandor launched Therapeutics like Thymoglobulin, Thyrogen, Synvisc from Genzyme and devices like the I-Stat Portable Clinical Analyser from I-Stat Corp. and other products from reputed manufacturers like, Cholestech Corp. Minntech Corporation, ITC and Respronics from USA and Dr. F Kohler Chemie from Germany. The company has also established an excellent network of sub dealers in the country to ensure proper service to users.
To further the company’s goals in bringing healthcare at affordable rates with highest level of efficacy to our patients, Sandor ventured into clinical research under a separate entity, Sandor Proteomics Pvt Ltd. The research is based on identifying biomarkers for various diseases and providing a platform for clinicians / other researchers to carry out studies to improve patient care in India. The company has set up a state of art laboratory with the aim to conduct superior research and provide clinical services to researchers. The company has collaboration with reputed clinicians and scientist in India and abroad for clinical and genomic research. The primary focus is to develop personalized medicine by identifying novel biomarkers for improving drug therapy. The company is committed to providing international laboratory standards to our researchers by strict compliance to GLP. |
|
